Robert Joseph Timko is a notable inventor based in West Chester, PA (US). He has made significant contributions to the field of pharmaceuticals, holding a total of 4 patents. His work focuses on developing innovative pharmaceutical compositions that address various medical conditions.

Latest Patents

Timko's latest patents include a pharmaceutical composition that comprises a specific physical form of N-[4-[5-(cyclopentyloxycarbonyl)amino-1-methylindol-3-yl-methyl]-3-methoxy benzoyl]-2-methyl-benzenesulphonamide and polyvinylpyrrolidone. This invention provides methods for preparing this physical form, as well as another physical form of the same compound, which is useful in treating diseases where leukotrienes are implicated, such as asthma. Another significant patent relates to sustained release formulations that include 11-4-2-(2-hydroxyethoxy)ethyl-1-piperazinyl-dibenzo[b,f]-1,4-thiazepine or a pharmaceutically acceptable salt thereof. This invention is aimed at treating psychotic states and hyperactivity through the use of these sustained release formulations.

Career Highlights

Timko is currently associated with Zeneca Limited, where he continues to innovate in the pharmaceutical sector. His work has been instrumental in developing new treatments that improve patient outcomes.

Collaborations

Throughout his career, Timko has collaborated with notable colleagues, including Randy J. Bradway and Arlene Clements. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Robert Joseph Timko's contributions to pharmaceutical innovations demonstrate his commitment to improving healthcare through science. His patents reflect a deep understanding of complex medical challenges and a dedication to finding effective solutions.